Pfizer (PFE) Financials
Pfizer (PFE) Historical Financial Statements and Key Metrics for 1994 - 2023
Full Pfizer financials for 1994 - 2023 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Pfizer Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2023-Dec-31 | 14,249 | 5,657 (39.7 %) | -1,593 (-11.2 %) | -3,344 (-23.5 %) | 77 | -0.59 |
| 2023-Oct-01 | 13,232 | 3,963 (30.0 %) | -1,982 (-15.0 %) | -2,382 (-18.0 %) | -803 | -0.42 |
| 2023-Jul-02 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2023-Apr-02 | 18,282 | 13,396 (73.3 %) | 7,293 (39.9 %) | 5,543 (30.3 %) | 8,396 | 0.97 |
| 2022-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2022-Oct-02 | 22,638 | 16,575 (73.2 %) | 9,666 (42.7 %) | 8,608 (38.0 %) | 10,458 | 1.51 |
| 2022-Jul-03 | 27,742 | 19,094 (68.8 %) | 12,409 (44.7 %) | 9,906 (35.7 %) | 12,944 | 1.73 |
Full historical income statements for 1994 - 2023 is included in the
US Historical Financials dataset.
Pfizer Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2023-Dec-31 | 226,501 | 137,213 | 75,041 | 89,014 | 12,690 |
| 2023-Oct-01 | 215,021 | 117,817 | 63,596 | 96,934 | 44,181 |
| 2023-Jul-02 | 220,168 | 120,875 | 65,341 | 99,019 | 44,785 |
| 2023-Apr-02 | 195,617 | 94,381 | 34,927 | 100,970 | 19,972 |
| 2022-Dec-31 | 197,206 | 101,289 | 34,870 | 95,661 | 22,732 |
| 2022-Oct-02 | 195,350 | 102,459 | 35,677 | 92,631 | 36,123 |
| 2022-Jul-03 | 195,290 | 107,821 | 40,284 | 87,208 | 33,304 |
Full historical balance sheet data for 1994 - 2023 is included in the
US Historical Financials dataset.
Pfizer Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2023-Dec-31 | 5,240 | -10,996 | 5,442 | 4,196 |
| 2023-Oct-01 | 3,456 | 888 | -3,779 | 2,646 |
| 2023-Jul-02 | -1,208 | -25,485 | 27,174 | -2,122 |
| 2023-Apr-02 | 1,212 | 3,315 | -2,771 | 73 |
| 2022-Dec-31 | 8,582 | -4,410 | -5,015 | 7,581 |
| 2022-Oct-02 | 5,974 | -627 | -5,761 | 5,133 |
| 2022-Jul-03 | 8,170 | -11,313 | 2,520 | 7,419 |
Full historical cash flow data for 1994 - 2023 is included in the
US Historical Financials dataset.
Pfizer Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2023-Dec-31 | 162,577 | 234,765 | 11.41 | -12.15 | 1.83 |
| 2023-Oct-01 | 191,625 | 252,073 | 14.48 | -20.11 | 1.98 |
| 2023-Jul-02 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2023-Apr-02 | 232,966 | 265,727 | 12.74 | 10.51 | 2.31 |
| 2022-Dec-31 | 287,713 | 322,167 | 11.84 | 14.40 | 3.01 |
| 2022-Oct-02 | 247,493 | 281,872 | 10.93 | 7.19 | 2.67 |
| 2022-Jul-03 | 288,823 | 327,327 | 10.41 | 7.29 | 3.31 |
Full historical valuation and operating metrics for 1994 - 2023 are included in the
US Historical Financials dataset.